dantrolene sodium hemiheptahydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle AUST R: 42975Active ingredients:
dantrolene sodium hemiheptahydrate
Dosage form:
Capsule
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
28 May 2018
to
31 Dec 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
|
DANTRIUM dantrolene sodium hemiheptahydrate 50mg capsule bottle AUST R: 42976Active ingredients:
dantrolene sodium hemiheptahydrate
Dosage form:
Capsule
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
31 May 2018
to
31 Dec 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An unregistered product containing dantrolene 25mg has been approved for supply under Section 19A. See the website https://www.tga.gov.au/resources/section-19a-approvals and search for the active ingredient.
|
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial AUST R: 14435Active ingredients:
dantrolene sodium hemiheptahydrate
Dosage form:
Injection, powder for
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
From
19 Jan 2026
to
30 Jan 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
The sponsor is closely controlling supply.
|